Skip to main content

Advertisement

Table 1 Characteristic of patients (N = 16)

From: Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study

Demographics  
Age (years)a 67.0 (58.0-71.0)
Sex (men/women) 11/5
BMI (kg/m2)a 25.0 (22.0-27.9)
Duration of diabetes (years)a 14.0 (8.5-24.75)
HbA1c (%)a 9.1 (8.3-10.4)
Glycated albumin (%)a 22.9 (19.8-26.8)
eGFR (mL/min/1.73 m2)a 70.0 (62.6-82.4)
Previous medication of diabetes  
Insulinb 7
Oral hypoglycemic agents  
Sulfonylureab 5
Metforminb 9
Alpha-glucosidase inhibitorb 4
Glinideb 2
DPP-4 inhibitorb 0
Administration of metformin at STEP 0b 10
  1. a: Median (interquartile range), b: Numbers.